Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.65 |
| ▸ | TSHR | P16473 | 7/20 | 0.53 |
| ▸ | LMNA | P02545 | 3/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.49 |
| ▸ | HTT | P42858 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.48 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.48 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.48 |
| ▸ | SERPINE1 | P05121 | 1/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31609323 | 1.00 | TDP1 (0.65) | TDP1TSHRLMNAALDH1A1L3MBTL1 | |
| SCHEMBL30416074 | 0.86 | TDP1 (0.85) | TDP1TSHRLMNAALDH1A1L3MBTL1 | |
| SCHEMBL6063013 | 0.86 | TDP1 (0.85) | TDP1TSHRLMNAALDH1A1L3MBTL1 | |
| SCHEMBL29449291 | 0.82 | TDP1 (0.67) | TDP1TSHRLMNAALDH1A1L3MBTL1 | |
| SCHEMBL113328 | 0.82 | TDP1 (0.67) | TDP1TSHRLMNAALDH1A1L3MBTL1 | |
| SCHEMBL17978239 | 0.82 | TDP1 (0.67) | TDP1TSHRLMNAALDH1A1L3MBTL1 | |
| SCHEMBL6412404 | 0.82 | TDP1 (0.54) | TDP1TSHRLMNAALDH1A1L3MBTL1 | |
| SCHEMBL11530630 | 0.81 | TSHR (0.79) | TDP1TSHRLMNAALDH1A1L3MBTL1 | |
| SCHEMBL11525680 | 0.81 | TDP1 (0.71) | TDP1TSHRLMNAALDH1A1L3MBTL1 | |
| SCHEMBL6063097 | 0.81 | TDP1 (0.76) | TDP1TSHRLMNAALDH1A1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 126 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4356894-A1 | SUSTAINABLE PRODUCT WITH MALODORS | Beiersdorf AG (DE) | 2024-04-24 | — | — | EP | claimed |
| US-4582635-A | SUSTAINED RELEASE | TAKASAGO PERFUMERY CO., LTD. (JP) | 1986-04-15 | — | — | US | claimed |
| EP-4237396-B1 | METHOD OF MITIGATING CONVERSION OF VOLATILE TERPENE SPECIES | GIVAUDAN SA (CH) | 2026-02-18 | — | — | EP | disclosed |
| US-20260027132-A1 | FRAGRANCE COMPOSITIONS AND USE THEREOF FOR IMPROVING SLEEP | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2026-01-29 | — | — | US | disclosed |
| EP-4237393-B1 | METHOD OF CAUSING CONVERSION OF VOLATILE TERPENE SPECIES | GIVAUDAN SA (CH) | 2025-12-24 | — | — | EP | disclosed |
| US-20250333368-A1 | METHOD OF MITIGATING CONVERSION OF VOLATILE TERPENE SPECIES | GIVAUDAN SA (CH) | 2025-10-30 | — | — | US | disclosed |
| US-12453736-B2 | Fragrance compositions and use thereof for improving sleep | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2025-10-28 | — | — | US | disclosed |
| EP-3164107-B1 | LACTONE-CONTAINING COMPOSITIONS FOR MALODOR ELIMINATION | TAKASAGO PERFUMERY CO LTD (JP) | 2025-09-03 | — | — | EP | disclosed |
| US-12351546-B2 | Method of mitigating conversion of volatile terpene species | GIVAUDAN SA (CH) | 2025-07-08 | — | — | US | disclosed |
| US-20250091984-A1 | FRAGRANCE AND FLAVOR MATERIALS | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2025-03-20 | — | — | US | disclosed |
| EP-4504693-A1 | FRAGRANCE AND FLAVOR MATERIALS | Takasago International Corporation (JP) | 2025-02-12 | — | — | EP | disclosed |
| EP-1441603-A2 | METHOD AND COMPOSITION FOR MENTHOLATION OF CHARCOAL FILTERED CIGARETTES | Vector Tobacco Inc. (US) | 2004-08-04 | — | — | EP | disclosed |
| WO-2003041521-A2 | METHOD AND COMPOSITION FOR MENTHOLATION OF CHARCOAL FILTERED CIGARETTES | VECTOR TOBACCO INC. (US) | 2003-05-22 | — | — | WO | disclosed |
| EP-0907357-A4 | NON-AQUEOUS CONTROLLED RELEASE PEST AND AIR CARE GEL COMPOSITION | PENNZOIL PROD CO (US) | 2001-08-22 | — | — | EP | disclosed |
| EP-0907357-A1 | NON-AQUEOUS CONTROLLED RELEASE PEST AND AIR CARE GEL COMPOSITION | PENNZOIL PRODUCTS COMPANY (US) | 1999-04-14 | — | — | EP | disclosed |
| US-5871765-A | AIR FRESHENER COMPRISING HYDROCABON, BLEND OF THERMOPLASTIC BLOCK COPOLYMERS, AIR CARE ACTIVE SUBSTANCES | PENNZOIL PRODUCTS COMPANY (US) | 1999-02-16 | — | — | US | disclosed |
| WO-1997031623-A1 | NON-AQUEOUS CONTROLLED RELEASE PEST AND AIR CARE GEL COMPOSITION | PENNZOIL PRODUCTS COMPANY (US) | 1997-09-04 | — | — | WO | disclosed |
| US-5260475-A | Esterification of hydroxybenzoic acids | RHONE-POULENC CHIMIE (FR) | 1993-11-09 | — | — | US | disclosed |
| US-4906488-A | Modification of permeant | ARCADE, INC. (US) | 1990-03-06 | — | — | US | disclosed |
| US-4582635-A | SUSTAINED RELEASE | TAKASAGO PERFUMERY CO., LTD. (JP) | 1986-04-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250091984-A1 | FRAGRANCE AND FLAVOR MATERIALS | TAS2R5, TAS2R8, NISCH | TDP1 3776/4885TSHR 4740/4885LMNA 3736/4885 |
| US-20260027132-A1 | FRAGRANCE COMPOSITIONS AND USE THEREOF FOR IMPROVING SLEEP | B2M, PER2, CHRM2 | TDP1 4445/4885TSHR 2078/4885LMNA 761/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.